Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved therapies are available for wAIHA ...
No data regarding hemolytic complications after double UCBT are available in the literature. We report a case of combined auto- and alloimmune hemolysis after double UCBT that proved fatal. A ...
Hemolytic anemia occurs when red blood cells are destroyed faster than your bone marrow can make them. This can be caused by diseases, autoimmune disorders, or cancer. The treatment depends on the ...
Hemolysis is a well-recognized complication of allogeneic bone marrow transplantation (BMT) and may be caused by immune and nonimmune mechanisms. Post transplant immune-mediated hemolysis may be the ...
Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias. Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ...
Hemolytic anemia is a condition where the body destroys red blood cells in the body faster than it produces them. This leads to a low red blood cell count and symptoms such as weakness, shortness of ...
A complete blood count (CBC) might suggest hemolytic anemia if your RBC, hemoglobin, and reticulocyte counts are low. But further testing may be required. Anemia occurs when you don’t have enough ...
Hemolytic anemia is a disorder where the body destroys red blood cells (RBCs), which are removed from the system before their normal life span of 120 days is over. Destruction of red blood cells is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results